Aortic Stenosis and Mitral Regurgitation Together: Two Patients, Discordant Severity
Two patients each carry a stenotic aortic valve and a leaking mitral valve at the same time, but in neither case do the two lesions carry equal weight. The disagreement in each case is about which valve is actually driving symptoms and risk, and whether treating it changes how the other one should be read.
W.H., a 74-year-old man, has kept the same vegetable beds behind his house for over twenty years, and it was his wife, not any symptom he'd have reported on his own, who noticed he'd stopped working them past twenty minutes at a stretch this summer — he used to go two hours without stopping. He has known moderate aortic stenosis for three years, followed on yearly echocardiograms that never quite crossed into severe range, and long-standing hypertension that has never been especially well controlled despite two medications. This year's echo added something new: moderate mitral regurgitation, of the secondary type, arising not from any problem with the mitral valve itself but from a left ventricle that has spent years working against both his stiffened aortic valve and his blood pressure, remodeling in ways that let the mitral leaflets stop coapting as tightly as they should.
The two findings are not necessarily independent facts sitting side by side; they may be one mechanism read twice. If the aortic valve's afterload burden is what stretched the ventricle enough to loosen the mitral valve, the real question isn't which valve to fix first, but whether fixing the aortic valve — even at a severity still formally called moderate — might correct the mitral regurgitation on its own, the way secondary MR is known to improve when its underlying driver resolves. His numbers do not leave room for the usual escape hatch: a dobutamine study exists to unmask a severe valve hiding behind a weak ventricle, and it applies only when the valve area is already under 1.0 square centimeter with a mean gradient under 40 and an ejection fraction under 50 percent. His valve area is 1.3 and his ejection fraction is 55, so the stenosis is moderate as measured, not moderate by artifact. What is genuinely unresolved is whether his symptoms belong to that moderate valve at all — a question an exercise stress echocardiogram can address, by documenting how far he actually gets, and by showing whether the gradient and the mitral regurgitation climb steeply under load or stay where they sit at rest.
Case A — At the bedside
I'd get an exercise stress echo before deciding anything about his mitral valve — not a dobutamine study, which is for the low-flow, low-gradient picture he doesn't have. His secondary regurgitation is very likely downstream of afterload burden, whichever way the true aortic severity turns out to read — and treating the mitral valve directly, when it isn't the primary problem, risks fixing the wrong lesion.
Agreed on getting better hemodynamic data first, but there's a practical surgical point worth raising now rather than later. If he ends up needing aortic valve replacement — whether his valve progresses to severe, or an exertional study reclassifies where his symptoms are coming from — and I'll grant that symptomatic moderate stenosis is not itself an indication to replace the valve; that question is being tested in trials and isn't settled guidance yet — the secondary MR should be reassessed intraoperatively, not assumed away beforehand. Functional MR doesn't always fully resolve once its primary driver is corrected, especially after years of remodeling, and being unprepared to address it in the same operation means sending him back for a second one later if it persists.
His hypertension is a real, independently correctable contributor here, separate from either valve. More aggressive antihypertensive optimization is worth doing now regardless of what the stress echo shows — he's on two agents and still well above goal — both because tighter control may itself reduce the secondary MR's severity, and because uncontrolled afterload will confound interpretation of any stress test performed while his pressure remains this high.
Agreed: exercise stress echocardiography to clarify how much of his symptom burden the moderate aortic valve actually accounts for, blood pressure optimization intensified regardless of the stress test's outcome.
Not agreed, and the reason the mitral valve's fate stayed genuinely open:
Shortened surveillance with a low threshold for aortic valve replacement once severity criteria are met, and reassessment of the mitral regurgitation at that point rather than on its own.
Continue surveillance of both valves, treating blood pressure as the primary modifiable driver in the meantime.
L.F., a 68-year-old woman, has spent thirty years on a hospital nursing floor without ever being the patient in the bed, which made it strange enough that she mentioned it to her own cardiologist almost as a joke — new palpitations partway through a shift, and a breathlessness walking the hallway that had nothing to do with how busy the floor was that day. She has known paroxysmal atrial fibrillation for two years, well controlled on apixaban, and a moderate aortic valve narrowing that has sat unchanged on three consecutive years of imaging. What's new this year is her mitral valve: a prolapsing posterior leaflet, degenerative rather than functional, now regurgitating severely by every echocardiographic criterion the lab uses.
Unlike a mitral valve that leaks because a ventricle has stretched around it, hers is the primary problem — the leaflet itself has failed mechanically, independent of anything happening elsewhere in her heart — and her new symptoms, the palpitations and the volume-type breathlessness, track that lesion specifically rather than the pattern a worsening aortic valve would produce. Her aortic stenosis, stable for three years running, isn't the thing that changed, and nothing in her recent decline points back to it. She has already cut her nursing shifts to part-time rather than push through the fatigue, a concession she says she resents making. The question in front of her surgical team isn't really which valve is driving her symptoms — that part reads clearly — it's whether her stable, moderate aortic valve should be addressed in the same operation as the mitral repair, or left alone and simply watched.
Case B — At the bedside
I'd favor a combined single operation: repair the mitral valve — technically feasible, since degenerative pathology like hers is typically repairable — and address the aortic valve in the same setting. Operating on a moderate aortic valve while an open mitral operation is already planned carries little incremental risk compared to a second operation years from now if her AS eventually progresses, and it avoids reoperative risk altogether.
Her aortic valve is genuinely stable, moderate, and asymptomatic in its own right. Replacing a moderate valve during another cardiac operation is a weak, conditional recommendation — reasonable to consider, not something the guideline directs — and adding an aortic procedure she has no independent indication for to an operation that doesn't otherwise need one increases cross-clamp time and procedural risk for a valve that may never need treatment in her lifetime. I'd favor mitral repair alone, with continued surveillance of the aortic valve on its own timeline.
"Little incremental risk" still isn't zero risk, and it's being added for a lesion that today gives her no reason to need it.
Worth naming the option that actually lowers the cost of waiting: if her aortic valve does eventually progress, her anatomy and the fact that a separate mitral operation won't complicate a future transcatheter approach the way it might complicate a future surgical one make her a strong future TAVR candidate. Watchful waiting on the aortic valve today doesn't foreclose a good option later — it just defers a decision that isn't needed yet.
Agreed: mitral valve repair planned; her aortic valve left untouched at this operation, given its stability and a concomitant-AVR recommendation that's real but only conditional — Class 2a, not mandatory.
Not agreed, and the reason her aortic valve's future stayed an open question rather than a closed one:
A transcatheter approach is favored, given her anatomy and the absence of any complication a prior sternotomy would otherwise raise.
No further aortic intervention is ever needed; today's mitral repair remains a one-time, single-valve operation.